The Role of PET and PET/CT in the Surgical Management of Breast Cancer: A Review

被引：1
作者：
Bahl, Susan [1 ]
Alavi, Abass [2 ]
Basu, Sandip [3 ]
Kumar, Rakesh [4 ]
Czerniecki, Brian J. [1 ,5 ]
机构：
[1] Univ Penn, Sch Med, Dept Surg, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Sect, Radiol, Philadelphia, PA 19104 USA
[3] BARC, Radiat Med Ctr, Bombay, Maharashtra, India
[4] All India Inst Med Sci, Dept Nucl Med, New Delhi 110029, India
[5] Univ Penn, Sch Med, Perelman Ctr 3, Dept Surg, Philadelphia, PA 19104 USA
来源：
PET CLINICS | 2009年 / 4卷 / 03期
关键词：
PET; PET/CT; Breast cancer; Surgical management;
D O I：
10.1016/j.cpet.2009.10.002
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
The role of PET and PET/CT in the management of patients with breast cancer is in evolution. Recent investigations suggest dual time point imaging increases sensitivity of detection of smaller breast cancers even DCIS suggesting PET imaging may offer some value in patients where mammography is typically not particularly sensitive. PET/CT may have its greatest role in staging, especially for patients with locally advanced breast cancer and can even predict response to neoadjuvant therapy. PET/CT may be particularly useful in predicting the biology of higher risk triple-negative and HER-2/neupositive tumors. PET/CT will continue to play a major role in the management of patients with breast cancer.
引用
收藏
页码：277 / 287
页数：11
相关论文
共 34 条
[1]  
Abouzied MM, 2005, J NUCL MED TECHNOL, V33, P145
[2]  
Adler Lee P, 2003, Breast J, V9, P163, DOI 10.1046/j.1524-4741.2003.09306.x
[3]   EVALUATION OF BREAST MASSES AND AXILLARY LYMPH-NODES WITH [F-18] 2-DEOXY-2-FLUORO-D-GLUCOSE PET [J].
ADLER, LP ;
CROWE, JP ;
ALKAISI, NK ;
SUNSHINE, JL .
RADIOLOGY, 1993, 187 (03) :743-750
[4]   Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose:: Use and limitations [J].
Avril, N ;
Rosé, CA ;
Schelling, M ;
Dose, J ;
Kuhn, W ;
Bense, S ;
Weber, W ;
Ziegler, S ;
Graeff, H ;
Schwaiger, M .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (20) :3495-3502
[5]   Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters [J].
Basu, Sandip ;
Chen, Wengen ;
Tchou, Julia ;
Mavi, Ayse ;
Cermik, Tevfik ;
Czerniecki, Brian ;
Schnall, Mitchell ;
Alavi, Abass .
CANCER, 2008, 112 (05) :995-1000
[6]   Implications of standardized uptake value measurements of the primary lesions in proven cases of breast carcinoma with different degree of disease burden at diagnosis: Does 2-Deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography predict tumor biology? [J].
Basu, Sandip ;
Mavi, Ayse ;
Cermik, Tevfik ;
Houseni, Mohamed ;
Alavi, Abass .
MOLECULAR IMAGING AND BIOLOGY, 2008, 10 (01) :62-66
[7]   False-negative MR imaging of malignant breast tumors [J].
Boetes, C ;
Strijk, SP ;
Holland, R ;
Barentsz, JO ;
VanderSluis, RF ;
Ruijs, JHJ .
EUROPEAN RADIOLOGY, 1997, 7 (08) :1231-1234
[8]  
Buscombe JR, 2004, Q J NUCL MED MOL IM, V48, P109
[9]  
Byrne AM, 2004, BR J SURG
[10]   Retrospective Studyof 18F-FDG PET/CT in the Diagnosis of Inflammatory Breast Cancer: Preliminary Data [J].
Carkaci, Selin ;
Macapinlac, Homer A. ;
Cristofanilli, Massirno ;
Mawlawi, Osama ;
Rohren, Eric ;
Angulo, Ana M. Gonzalez ;
Dawood, Shaheenah ;
Resetkova, Erika ;
Le-Petross, Hliong T. ;
Yang, Wei-Tse .
JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (02) :231-238
1234